The down scheduling of prolonged-release melatonin to Pharmacist-Only for the management of primary insomnia in people aged over 55 years old came into effect on 1 June 2021.
From this time, pharmacists have a greater role to play in providing information and support to patients with insomnia, including the supply of melatonin in line with the TGA decision.
Guild Learning and Development has partnered with Aspen Australia in the development of a new online course titled ‘Melatonin for the management of insomnia’ to assist pharmacists navigate this new area.
The course educates pharmacists on the science of sleep, the role of melatonin, and when to recommend melatonin to patients.
It focuses on Circadin® (prolonged release melatonin), and increasing pharmacist confidence when speaking with patients about sleep and the counselling points for melatonin use.
To enrol in this course please visit guilded.guild.org.au
